Clinical trials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Completed | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Princess Maxima Center for Pediatric Oncology | 3 |
| Cellestia Biotech AG | 1 |
| Daiichi Sankyo | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| GlaxoSmithKline | 1 |
| Gyala Therapeutics | 1 |
| Institut Català d'Oncologia | 1 |
| OneChain Immunotherapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 10 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Recurrence | 4 |
| Breast Neoplasms | 3 |
| Leukemia | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Hodgkin Disease | 2 |
| Immunoblastic Lymphadenopathy | 2 |
Trials
Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.